ArticleCancer science2022

Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab.

Shuhei Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.